The ALK inhibitors, alectinib and ceritinib, induce ALK‐independent and STAT3‐dependent glioblastoma cell death-Reference-Cited by-同舟云学术

The ALK inhibitors, alectinib and ceritinib, induce ALK‐independent and STAT3‐dependent glioblastoma cell death

Published:2021-05 Issue:6 Volume:112 Page:2442-2453
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Kawauchi Daisuke¹²,Takahashi Masamichi¹³^ORCID,Satomi Kaishi¹⁴,Yamamuro Shun¹⁵,Kobayashi Tatsuya¹⁶,Uchida Eita¹⁷,Honda‐Kitahara Mai¹,Narita Yoshitaka³,Iwadate Yasuo²,Ichimura Koichi¹^ORCID,Tomiyama Arata¹⁸^ORCID

Affiliation:

1. Division of Brain Tumor Translational Research National Cancer Center Research Institute Tokyo Japan

2. Department of Neurological Surgery Chiba University Graduate School of Medicine Chiba Japan

3. Department of Neurosurgery and Neuro‐Oncology National Cancer Center Hospital Tokyo Japan

4. Department of Pathology and Clinical Laboratories National Cancer Center Hospital Tokyo Japan

5. Department of Neurological Surgery Nihon University School of Medicine Tokyo Japan

6. Department of Neurosurgery Tokyo Women's Medical University Tokyo Japan

7. Department of Neuro‐Oncology/Neurosurgery Saitama Medical University International Medical Center Hidaka‐City Japan

8. Department of Neurosurgery National Defense Medical College Tokorozawa Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14885

Reference39 articles.

1. Comparative Brain and Central Nervous System Tumor Incidence and Survival between the United States and Taiwan Based on Population-Based Registry

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. Advances in studies of tyrosine kinase inhibitors and their acquired resistance

4. Receptor tyrosine kinase targeting in glioblastoma: Performance, limitations and future approaches;Alexandru O;Contemp Oncol (Pozn),2020

5. Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment;International Journal of Molecular Sciences;2024-01-23

2. Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings;Brain Sciences;2023-11-17

3. ALK fusions in the pan-cancer setting: another tumor-agnostic target?;npj Precision Oncology;2023-09-29

4. Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies;International Journal of Molecular Sciences;2023-06-21

5. An update on Alectinib: a first line treatment for ALK-positive advanced lung cancer;Expert Opinion on Pharmacotherapy;2023-06-13